מלזיה - אנגלית - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

boehringer ingelheim (malaysia) sdn. bhd. - metformin hydrochloride; empagliflozin -

סינגפור - אנגלית - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - dabigatran etexilate mesilate 126.83 mg eqv dabigatran etexilate - capsule - 110 mg - dabigatran etexilate mesilate 126.83 mg eqv dabigatran etexilate 110 mg

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) limited - tiotropium bromide monohydrate 22.5ug equivalent 18 µg tiotropium - powder filled inhalation capsule - 18 mcg - active: tiotropium bromide monohydrate 22.5ug equivalent 18 µg tiotropium excipient: gelatin lactose monohydrate - spiriva is indicated for the long term once daily maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema. spiriva reduces the frequency of exacerbations and improves exercise tolerance and health-related quality of life.

סינגפור - אנגלית - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - linagliptin; metformin 779.83mg eqv. metformin hydrochloride - tablet, film coated - 2.500mg - linagliptin 2.500mg; metformin 779.83mg eqv. metformin hydrochloride 1000.000mg

סינגפור - אנגלית - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - linagliptin; metformin 389.91mg eqv. metformin hydrochloride - tablet, film coated - 2.500mg - linagliptin 2.500mg; metformin 389.91mg eqv. metformin hydrochloride 500.000mg

סינגפור - אנגלית - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - linagliptin; metformin 662.85mg eqv. metformin hydrochloride - tablet, film coated - 2.500mg - linagliptin 2.500mg; metformin 662.85mg eqv. metformin hydrochloride 850.000mg

ארצות הברית - אנגלית - NLM (National Library of Medicine)

boehringer ingelheim pharmaceuticals, inc. - nevirapine (unii: 99dk7fvk1h) (nevirapine - unii:99dk7fvk1h) - nevirapine 400 mg - viramune xr is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv-1) infection in adults and pediatric patients 6 years of age or older with a body surface area (bsa) of 1.17 m2 or greater [see clinical studies (14.1, 14.2)] . limitations of use: - adult females with cd4+ cell counts greater than 250 cells/mm3 or - adult males with cd4+ cell counts greater than 400 cells/mm3 [see warnings and precautions (5.1)]. viramune xr is contraindicated: - in patients with moderate or severe (child-pugh class b or c, respectively) hepatic impairment [see warnings and precautions (5.1) and use in specific populations (8.7)] . - for use as part of occupational and non-occupational post-exposure prophylaxis (pep) regimens [see warnings and precautions (5.1)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to nevirapine during pregnancy. healthcare providers are encouraged to register pat

מלזיה - אנגלית - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

boehringer ingelheim (malaysia) sdn. bhd. - metformin hydrochloride; linagliptin -

מלזיה - אנגלית - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

boehringer ingelheim (malaysia) sdn. bhd. - metformin hydrochloride; linagliptin -

מלזיה - אנגלית - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

boehringer ingelheim (malaysia) sdn. bhd. - metformin hydrochloride; linagliptin -